PeekMed® receives FDA 510(k) clearance to take its orthopedic planning system into the US market

Braga, Portugal – Dec. 3, 2018 – PeekMed® reached510(k) clearance for its orthopedic planning system, from the U.S. Food and Drug Administration (FDA), after regulatory approval in the European Union, and successfully working with more than 1100 surgeons. Developing a product in the medical field is highly demanding when it comes to regulation. Only a few European companies achieve certification in the USA due to the detailed evaluation and responsibility attributed by this certification.

After being certified as a class I with measuring function in the European Union, PeekMed® has received FDA 510(k) clearance. It verifies the technical, safety, and performance information about the medical device, allowing to enter in the USA market.

PeekMed® is a new 3D digital system that brings orthopedic surgeons the ability to secure the best patient outcomes by planning faster, safer and easier than ever while reducing surgery time and cost.  With this certification, health professionals all across the USA will be able to digitally perform the surgical planning without changing their surgical process or requirements. The system now uses any standard patients’ medical images, such as X-Rays, CT or MRI scan, which can be imported from a CD ROM, a local folder or local PACS (Picture Archiving and Communication Systems). In addition, the surgeon can use a database of prosthetic templates from several orthopedic implant manufacturers to select the most suitable implant for the patient to maximize overall efficiency and outcomes.

“PeekMed® was designed with surgeons for surgeons. Therefore, this is an incredible achievement for the company as it allows us to deliver the product to the largest market globally! Our goal is to provide the best pre-operative planning system to improve the outcomes of the 6.6 million surgeries expected in 2020. This now continues with every single surgeon across the US.” says João Pedro Ribeiro, PeekMed®’s CEO.

With the FDA approval, there is a bright future ahead for PeekMed® and Dr. François Lintz, Orthopedic surgeon and Chair in scientific committee at the French Foot and Ankle Society underlines: “PeekMed® is the first user-friendly system which enables precise surgical 3D planning. Being able to simulate surgical cuts and virtually adapt the implants to the patient’s own anatomy is really a game changer.”

The system is designed for surgical medical specialties and its expansion will not stop any time soon. The constant improvements through research and improvement of the technology in the orthopedic field are something that PeekMed® is always seeking. This is one more step towards bringing the best technology into the orthopedic industry.

About Peter Coffaro 603 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.